Back
Ascendis Pharma AS Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
41
ASND
Ascendis Pharma AS
Last Price:
147.00
Seasonality Move:
6.54%
Sell
28
ALNY
Alnylam Pharmaceuticals
Last Price:
272.71
Seasonality Move:
5.61%
Sell
41
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $146.59. The Score for ASND is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $274.46. The Score for ALNY is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $146.59
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $274.46
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ASND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.42 | Sell |
Relative Strength Index (14 RSI): | 66.82 | Buy |
Chaikin Money Flow: | 1073571 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (121.38 - 142.52) | Buy |
Bollinger Bands (100): | (125.48 - 139.4) | Buy |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.95 | Buy |
Relative Strength Index (14 RSI): | 59.65 | Buy |
Chaikin Money Flow: | 719597 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (256.31 - 277.53) | Buy |
Bollinger Bands (100): | (161.67 - 267.41) | Buy |
ASND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 122.89 | Buy |
20-day SMA: | 130.17 | Buy |
50-day SMA: | 132.66 | Buy |
200-day SMA: | 135.12 | Buy |
8-day EMA: | 128.84 | Buy |
20-day EMA: | 128.79 | Buy |
50-day EMA: | 131.25 | Buy |
200-day EMA: | 129.25 | Buy |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 261.21 | Buy |
20-day SMA: | 266.87 | Buy |
50-day SMA: | 259.05 | Buy |
200-day SMA: | 190.61 | Buy |
8-day EMA: | 265.35 | Buy |
20-day EMA: | 263.87 | Buy |
50-day EMA: | 251.75 | Buy |
200-day EMA: | 206.68 | Buy |
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.77 per share, an increase next quarter of $1.90 per share, an increase this year of $1.68 per share, and an increase next year of $4.41 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.57 per share, an increase next quarter of $0.47 per share, an increase this year of $1.30 per share, and an increase next year of $0.57 per share.
Ascendis Pharma AS Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |